8 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
Multidrug-Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis ... #MDRTB #management ... antimicrobials #pharmacology ... #dosing #idsa #
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Multi-Drug Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis ... #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... Guidelines for dosing ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Tuberculosis Dosing Recommendations for Adult Patients With Reduced Renal Function (CKD)
Isoniazid 300 mg once daily, or
Tuberculosis Dosing ... not daily) #Tuberculosis ... #Dosing #CKD #pharmacology ... #medications #management
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
to Table 5 for dosing ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
best prevented by using ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology